期刊文献+

梅毒螺旋体黏附素Tp0751核酸菌影的构建及免疫原性研究 被引量:3

Construction and immunocompetence of recombinant DNA E. coli ghosts expressing Treponema pallidum adhesin Tp0751
下载PDF
导出
摘要 目的:构建梅毒螺旋体(Tp)黏附素Tp0751的重组真核大肠埃希菌菌影(EBG)并检测其在免疫鼠中的免疫原性,为探讨新型梅毒疫苗奠定基础。方法:构建pc DNA3.1(+)/Tp0751真核表达载体,将其装载入已构建的空EBG中,形成重组核酸菌影pc D/Tp0751-BG,计算装载率;将核酸菌影转染鼠源性巨噬细胞RAW264.7,Western blot(WB)鉴定目的蛋白表达。将雌性BALB/c鼠随机分为A(PBS)、B(空EBG)、C(空pc DNA3.1)三个对照组和D(pc D/Tp0751)、E(pc D/Tp0751-BG)、F(pc D/Tp0751-BG+r Tp0751)三个实验组,各组间隔两周肌注免疫共三次,检测特异性血清Ig G及生殖道黏膜SIg A、小鼠脾细胞增殖水平和分泌IFN-γ水平。结果:重组真核质粒对菌影的装载率为76.1%;WB显示此转染细胞能有效表达重组目的蛋白。D、E、F实验组小鼠特异性血清Ig G与生殖道SIg A效价均随免疫次数增加而增加,各时间点均显著高于三个对照组(P<0.01),于末次加免后第8周达到峰值,此时F组Ig G与SIg A效价分别为1∶102 400与1∶12 800;首次加免2周后,E、F组均显著高于D组(P<0.01);末次加免2周后,F组显著高于E组(P<0.01)。末次加免后第8周,D、E、F组的刺激指数(SI)值与IFN-γ水平均分别显著高于三个对照组(P<0.01);E、F组均分别显著高于D组(P<0.01);F组分别均高于E组(P<0.05)。结论:Tp0751真核质粒菌影具有良好的免疫原性,在小鼠体内诱生了有效的系统和黏膜的体液应答以及系统细胞免疫应答;异源加免较同源加免免疫效果更好。 Objective:To construct the recombinant DNA E.coli ghosts(EBGs)expressing Treponema pallidum adhesin Tp0751(pcD/Tp0751-BG)and determine its immunocompetence in immunized mice,and provide a potential novel method for syphilis vaccine developing.Methods:The recombinant eukaryotic expression plasmid pcDNA3.1(+)/Tp0751 was constructed and loaded into empty EBGs to create pcD/Tp0751-BG.The loading rate was determined accordingly.Macrophages cell line RAW264.7 was transfected with pcD/Tp0751-BG,and the expression of recombinant Tp0751(rTp0751)protein was detected by Western blot(WB).For immunocompetence in mice,the female BALB/c mice were randomly divided into 6 groups,including three control groups,A(PBS),B(EBG),C(empty pcDNA),and experimental group D(naked pcD/Tp0751),E(pcD/Tp0751-BG)and F(pcD/Tp0751-BG+rTp0751).All the mice were immunized as indicated for three times by intramuscular injection at two weeks intervals.The levels of specific IgG in sera and SIgA in genital tract lavage fluid were measured by ELISA.Levels of lymphocyte proliferation and IFN-γsecretion in spleen cells were measured by CCK-8 Cell Counting Kit and ELISA as well,respectively.Results:The loading rate of pcD/Tp0751 to EBGs was 76.1%.WB showed that the target recombinant protein pcD/Tp0751 expressed in RAW264.7 cells was active with Tp-infected rabbit sera.The titers of specific IgG and SIgA in group D,E,F gradually increased to significantly higher level as compared to the control groups(P<0.01),which reached its peak at wk 8 after last immunization(the titers of IgG and SIgA were 1∶102 400 and 1∶12 800 in group F,respectively).Higher levels of specific IgG and SIgA were observed in groups E and F as compared to group D after first boost(P<0.01),with groups F higher than group E after last boost(P<0.01).At wk 8 after the last boost,the stimulation index(SI)and levels of IFN-γin group D,E,F were all significant higher than the control groups(P<0.01),with group E and F higher than group D(P<0.01),and group E higher than group F(P<0.05).Conclusion:The recombinant DNA EBGs of T.pallidum adhesin Tp0751(pcD/Tp0751-BG)possesses the immunocompetence to induce not only strong mucosal and systemic humoral immune response but also systemic cellular immune response in BALB/c mice.The heterologous boost can be more efficient than homologous boost during immunization process.
作者 张佳俐 曹二龙 曹龙古 赵飞骏 余坚 唐一之 符波 段武 曾铁兵 ZHANG Jia-Li;CAO Er-Long;CAO Long-Gu;ZHAO Fei-Jun;YU Jian;TANG Yi-Zhi;FU Bo;DUAN Wu;ZENG Tie-Bing(Institute of Pathogenic Biology,University of South China,Hengyang 421001,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2018年第4期508-512,519,共6页 Chinese Journal of Immunology
基金 本文受国家自然科学基金(81273322 81373230)、湖南省分子靶标新药研究协同创新中心项目(湘教通[2014]405号)、特殊病原体防控湖南省重点实验室资助项目(湘科计字2014-5号)、湖南省教育厅开放创新平台基金(15K110)和湖南省教育厅资助科研项目(15C1256 17B245)资助。
关键词 梅毒螺旋体 Tp0751 核酸疫苗 菌影 免疫原性 Treponema pallidum Tp0751 Nucleic acid vaccine Bacterial ghost Immunocompetence
  • 相关文献

参考文献2

二级参考文献35

  • 1Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease [J]. N Engl J Med,2001,344(18) :1378-1388.
  • 2Raymond J. Neisseria meningitidis : eharacterisation and epidemiology[ J]. Arch Pediatr,2012,19 ( Suppl 2 ) : $55-60.
  • 3Ferguson LE, Hormann MD, Parks DK, et al. Neisseria meningitidis : presentation, treatment, and prevention [ J 3. Pediatr Health Care,2002,16 ( 3 ) : 119-124.
  • 4Jackson LA, Jaeobson RM, Reisinger KS, et al. A randomized trial to deter mine the tolerabi]ity and immunogenieity of a quadrivalent meningococeal glycoeonjugate vaccine in healthy adolescents [ J ]. Pediatr Infect Dis J,2009,28(2) :86-91.
  • 5van den Dobbelsteen GP, van Dijken HH, Pillai S, et al. Immunogenieity of a combination vaccine containing pneumoeoecal conjugates and meningococcal PorA OMVs [J].Vaccine, 2007,25 ( 13 ) :2491-2496.
  • 6Aaberge IS, Oster P, Helland OS, et al. Combined ad ministration of meningococeal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of menin- goeoeeal disease is safe and immunogenie [ J ]. Clin Diagn Lab Immuno1,2005,12(5 ) :599-605.
  • 7Trotter CL, Ramsay ME. Vaccination against meningoeoeeal disease in Europe:review and recommendations for the use of conjugate vaccines[ J]. FEMS Mierobiol Rev ,2007,31 ( 1 ) : 101-107.
  • 8Holst J, Martin D, Arnold R, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis [ J ]. Vaccine, 2009,27 ( Suppl 2 ) : B3-12.
  • 9Esposito S, Castellazzi L, Boseo A,et al. Use of a muhieomponent, recombinant, meningococcal serogroup B vaccine ( 4CMenB ) for baeterlal meningitis prevention [ J ]. Immunotherapy, 2014,6 ( 4 ) : 395 -408.
  • 10Bruge J,Bouveret-Le CN, Danve B,et al. Clinical evaluation of a group B meningocoecal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers [ J ]. Vaccine, 2004,22 ( 9-10 ) : 1087-1096.

共引文献3

同被引文献11

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部